Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

Author： Jones Drew R   Miller Grover P  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.7, 2011-07, pp. : 857-874

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idarucizumab: What Should We Know?

By  

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite

WHAT WE KNOW AND WHAT WE NEED TO KNOW ABOUT DEVELOPMENTAL ALUMINUM TOXICITY

By Golub Mari S.   Domingo Jose L.  

Journal of Toxicology and Environmental Health, Vol. 48, Iss. 6, 1996-08 ,pp. : 585-598

Taylor & Francis Ltd

Access to resources Recommend Favorite

Editorials (Stem Cell Tourism in the Era of Personalized Medicine: What We Know, and What We Need to Know)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 2, 2012-06 ,pp. : 106-110

Bentham Science Publishers

Access to resources Recommend Favorite

ACE Inhibitors in Heart Failure: What More Do We Need to Know?

By Demers Catherine   Mody Anita   Teo Koon K.   McKelvie Robert S.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

Adenosine Receptors: What We Know and What We are Learning

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 9, 2010-06 ,pp. : 860-877

Bentham Science Publishers

Access to resources Recommend Favorite